Like Bangalore, the city of Chennai in the southern Indian state of Tamil Nadu is a key hub for the country’s biotech industry. Chennai, which manages AstraZeneca’s IT operations in the country at the Global Technology Centre, is home to more than 50 companies largely concentrating on biochemical production and assay test production.
Earlier this year, the government of Tamil Nadu participated in the Swiss Biotech Day convention held in Basel, Switzerland, which has a thriving biotech group, putting the city on the map of its progress in the industry globally. Here is a list of six Chennai biotech corporations that have made their mark on the industry.
Founded in 2014, Acrannolife Genomics developed the Trunome liquid biopsy, which is a non-invasive diagnostic measure capable of detecting chronic disorders using a blood test.
The control can monitor the fitness of organs that have been transplanted, adding kidneys, liver, heart, lungs and pancreas, to recovery after transplantation. This is done by analyzing DNA from blood received from the transplanted organ.
The Chennai-founded biotech company also specializes in Covid 19 verification, for which it established COVIQWIK, in collaboration with the Indian Council of Medical Research (ICMR). COVIQWIK is based on the RT-LAMP generation, a type of verification used for viral RNA detection, which can produce effects within an hour. Said to have 100% sensitivity and expression, the test, unlike polymerase chain reaction tests, does not require thermal cycling, as it is performed at a fast constant temperature.
In a non-equity grant, the company secured $181,000 in funding in February of this year. Biotech raised a total of $422,000 in four investments.
Collagen plays a key role in wound and scar healing, as it helps stimulate tissue expansion and angiogenesis (the formation of new blood vessels) and promotes epithelialization, a procedure in which skin epithelial cells move upward to promote repair, in wound treatment. As a component of its wound care program, Eucare Pharmaceuticals has developed Kollagen, which is a local collagen membrane with a bovine extracellular matrix that acts as a skin replacement for the remedy of superficial and deep skin burns.
He also created Kollagen-M, a porous collagen dressing for burns. It is a bovine collagen membrane that facilitates the healing mechanism of inflamed burns and is sold with a preservation medium. In addition, its NeuSkin sterile collagen membrane, a freeze-dried formula unlike Kollagen-M, is also composed of bovine collagen. All of these products have been gamma sterilized to prevent microbial infections and are available in other sizes.
In addition, it also manufactures GelSpon, which are absorbable hemostatic gelatin sponges of bovine origin, for surgical procedures to maintain homeostasis, a temperature and fluid regulation procedure that tends to become unbalanced after surgery. The company also focuses on scar and vitiligo treatments.
Founded in 1996, the Chennai-based biotech has collaborated with French company Urgo Laboratories, whose proprietary TLC gelled healing matrix composed of hydrocolloid, fatty residues and polymers, is helping with restorative care.
Since its establishment in 2004, Genex India Bioscience has been a distributor of mobile culture products. Over the years, it has expanded its scope to molecular biology.
The company sells its quantitative polymerase chain reaction (QPCR) kits, restriction enzymes, test kits, reagents and antibodies. As a service provider, GeneX India Bio Science assists in the progression of traditional antibody, gene and peptide synthesis. and scaled to other quantities. For peptide synthesis, for which the company has more than 20 years of experience, it can expand highly modified peptides in giant quantities. It also plays epigenomic profiling that refers to chromatin, RNA sequencing and DNA methylation analysis. The Chennai-based biotech company’s antibody progression includes the production of antibody fragments as part of a 28-day protocol.
The company, which won the exmobility award for India’s fastest developing company, has partnered with biotech companies around the world on projects such as U. S. analytical tools provider Thermo Scientific, French gene and mobile processing company Polyplus, German biotech PAN Biotech, known for Marrowpan, a medium for mobile bone marrow culture, and U. S. -based MagBio Genomics. U. S. Among many others.
Despite being the largest manufacturer at the time of completion and vegetables, around 40% of harvested crops rot before reaching the Indian market. According to the Food and Agriculture Organization of the United Nations, GreenPod Labs aims to combat this crisis.
Founded in 2019 in Chennai, the biotech company has discovered a way to extend the lifespan of crops. Biotechnology has manufactured bags involving powdered formulations of bioactive ingredients designed to activate crop defense systems, preventing spoilage. These come with plant extracts such as tree bars, fruit and vegetable skins and leaves, which are encapsulated in polymers.
The company’s first product was developed to protect ripe mangoes, which tend to melt during transportation. The bioactive prevents the skin from melting, to prevent microbial growth.
GreenPod Labs has raised a total of $651,500 in two s of funding, the latter taking a stand last year, which featured participation from angel investor organization Indian Angel Network and Amsterdam-based startup investor Rockstart.
With programs ranging from herbal fertilizers to use as biofuel, algae development can repair some of the damage to the environment as it can eliminate carbon emissions. Seagrass Technologies of India uses harvest generation to grow marine microalgae from seawater.
As algae capture carbon dioxide, the generation aspires to a sustainable life. The company’s SeaCarotene consists of the red marine microalgae Dunaliella Salina, in powder form. It contains the antioxidant beta-carotene, which is an orange-red pigment found in some vegetables such as carrots. SeaCarotene can be used in pigments, dyes, cosmetics, animal feed and as food supplements. Incorporated into the diet, it can promote herbal detoxification, maintain immune health, and protect against free radical damage. The company also manufactures SeaLipro, which is a powdered edition of the green algae Chlorella salina, as well as SeaProtein, which contains blue-green spirulina. Ideal complement. In addition to the benefits of SeaCarotene, SeaProtein and SeaLipro can also be used as superfood blends.
Established in 2016 in Chennai, the biotech company raised $80,000 in a pre-seed investment that was positioned in 2019. The investment was from investors such as Hong Kong-based venture capital corporation Brinc.
Founded in 2017, Solara Active Pharma Sciences is a biopharmaceutical production company that produces everything from immunosuppressants, anesthetics, antibiotics to treatments for glaucoma and diabetes. This includes more than 60 medications such as albendazole, ibuprofen, and levetiracetam, among others.
The biotech company has six production facilities in southern India, with reactors ranging in size from 250 litres to 12,500 litres, and a study and development centre in Chennai. The company’s kilo laboratory, a scale laboratory, can produce quantities of 500 g to 10 kg of clinical-grade material. For procedural engineering, it has a calorimetry device, a directed beam reflectance measurement (FBRM), which is a tool used to monitor and crystal size, a Radleys reactor that can mimic plant conditions, and an immediate screening device (RSD). The company also provides artificial progression and analytical centers to other companies.
As part of an equity round, Solara Active Pharma Sciences raised $30 million in 2019, funded through U. S. equity firm TPG Growth.
“*” Required fields
Engage and shape biopharmaceutical partnerships
Build relationships with world-class education at more than 250 institutes
“*” Required fields